SAN DIEGO – ResMed revenue for the quarter ended March 31, 2018 was $591.6 million, a 15% increase compared to the same period of the prior year. “We had a strong quarter, with solid revenue growth at the top line, and operating leverage improving the bottom line,” said ResMed CEO Mick Farrell. “Our cloud-connected medical device strategy is succeeding; the major markets for our sleep business are adopting remote monitoring systems, which plays to the strength of our offerings. Our mask business performed well across all markets, and our cloud-based software-as-a-service business also grew rapidly in Q3.”
Third quarter revenue in the United States, Canada and Latin America, excluding Brightree, was $317.5 million, a 7% increase over the same period of the prior year. Brightree revenue for the third quarter was $39.9 million, an increase of 14% compared to the same period of the prior year. Revenue in combined Europe, Asia and other markets was $234.2 million, an increase of 16% on a constant currency basis, compared to the same period of the prior year.
ResMed will be exhibiting at Medtrade, scheduled for Oct 15-17, 2018, at the Georgia World Congress Center in Atlanta. Look for early registration opportunities in mid June 2018.